These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 23990283
21. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S. J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327 [Abstract] [Full Text] [Related]
22. Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data. Camm AJ, Karayal ON, Meltzer H, Kolluri S, O'Gorman C, Miceli J, Tensfeldt T, Kane JM. CNS Drugs; 2012 Apr 01; 26(4):351-65. PubMed ID: 22452529 [Abstract] [Full Text] [Related]
23. Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study. Vieta E, Panicali F, Goetz I, Reed C, Comes M, Tohen M, EMBLEM Advisory Board. J Affect Disord; 2008 Feb 01; 106(1-2):63-72. PubMed ID: 17582508 [Abstract] [Full Text] [Related]
24. The antidepressant effects of risperidone and olanzapine in bipolar disorder. McIntyre RS, Mancini DA, Srinivasan J, McCann S, Konarski JZ, Kennedy SH. Can J Clin Pharmacol; 2004 Feb 01; 11(2):e218-26. PubMed ID: 15520475 [Abstract] [Full Text] [Related]
25. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M. J Clin Psychiatry; 2009 Oct 01; 70(10):1424-31. PubMed ID: 19906346 [Abstract] [Full Text] [Related]
26. Effectiveness of switching to ziprasidone for stable but symptomatic outpatients with schizophrenia. Weiden PJ, Simpson GM, Potkin SG, O'Sullivan RL. J Clin Psychiatry; 2003 May 01; 64(5):580-8. PubMed ID: 12755663 [Abstract] [Full Text] [Related]
31. Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia. Breier A, Berg PH, Thakore JH, Naber D, Gattaz WF, Cavazzoni P, Walker DJ, Roychowdhury SM, Kane JM. Am J Psychiatry; 2005 Oct 01; 162(10):1879-87. PubMed ID: 16199834 [Abstract] [Full Text] [Related]
33. Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study. Park S, Yi KK, Kim MS, Hong JP. Behav Brain Funct; 2013 Jul 19; 9():27. PubMed ID: 23866300 [Abstract] [Full Text] [Related]
37. Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study. Findling RL, Atkinson S, Bachinsky M, Raiter Y, Abreu P, Ianos C, Chappell P. J Child Adolesc Psychopharmacol; 2022 Apr 19; 32(3):143-152. PubMed ID: 35394365 [Abstract] [Full Text] [Related]
39. Quetiapine alone and added to a mood stabilizer for serious mood disorders. Sajatovic M, Brescan DW, Perez DE, DiGiovanni SK, Hattab H, Ray JB, Bingham CR. J Clin Psychiatry; 2001 Sep 19; 62(9):728-32. PubMed ID: 11681770 [Abstract] [Full Text] [Related]
40. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial. Durgam S, Starace A, Li D, Migliore R, Ruth A, Németh G, Laszlovszky I. Bipolar Disord; 2015 Feb 19; 17(1):63-75. PubMed ID: 25056368 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]